株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

血小板凝集能関連デバイスの世界市場の予測 〜2020年:製品 (システム・試薬・消耗品・付属品)・用途 (研究・診断・CVD・整形外科・外傷)・エンドユーザー別

Platelet Aggregation Devices Market by Product (Systems, Reagents, Consumables, Accessories), Application (Research, Diagnostic, CVD, Orthopedic, Trauma), End User (Hospitals, Diagnostic Laboratories, Academia, Blood Banks) - Global Forecasts to 2020

発行 MarketsandMarkets 商品コード 336987
出版日 ページ情報 英文 137 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
血小板凝集能関連デバイスの世界市場の予測 〜2020年:製品 (システム・試薬・消耗品・付属品)・用途 (研究・診断・CVD・整形外科・外傷)・エンドユーザー別 Platelet Aggregation Devices Market by Product (Systems, Reagents, Consumables, Accessories), Application (Research, Diagnostic, CVD, Orthopedic, Trauma), End User (Hospitals, Diagnostic Laboratories, Academia, Blood Banks) - Global Forecasts to 2020
出版日: 2015年08月07日 ページ情報: 英文 137 Pages
概要

血小板凝集能関連デバイスの市場は2015年から2020年にかけて21.0%のCAGRで推移し、2020年には3億4240万ドルの規模に達すると予測されています。米国、ドイツ、フランス、英国などの成熟市場が大きな市場規模を有しており、予測期間中は北米地域 (特に米国) が最大のCAGRを記録すると予測されています。対象疾患の発症率の増加や高齢者人口の増加、血小板凝集計技術の進歩、産学連携の拡大、臨床研究の増加などが同市場の成長に貢献しています。

当レポートでは、世界の血小板凝集能関連デバイスの市場について調査し、血小板凝集および血小板凝集能検査の概要、関連の製品・消耗品の種類と概要、関連製品・消耗品市場への各種影響因子の分析、市場全体および製品・用途・エンドユーザー・地域/主要国別の市場分析および市場成長予測、競合環境と市場シェア、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 世界市場の予測
  • 世界市場の予測:地域別
  • 製品別市場の現状
  • 世界市場の予測:用途別
  • 世界市場の予測:エンドユーザー別

第5章 市場概要

  • イントロダクション
  • 市場区分
  • 市場力学
    • 推進要因
    • 抑制要因
    • 市場機会
    • 課題

第6章 血小板凝集能関連デバイスの市場:製品別

  • イントロダクション
  • システム
  • 試薬
  • 消耗品・付属品

第7章 血小板凝集能関連デバイスの市場:用途別

  • イントロダクション
  • 臨床用途
    • 心血管系
    • 整形外科
    • その他
  • 研究用途

第8章 血小板凝集能関連デバイスの市場:エンドユーザー別

  • イントロダクション
  • 独立系病院
  • 診断ラボ
  • 研究機関・学術機関
  • その他

第9章 血小板凝集能関連デバイスの市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • その他
  • その他の地域

第10章 競合環境

  • 概要
  • 市場シェア分析
  • 競合シナリオ
  • 近年の発展動向
    • 新製品の開発・製品の強化
    • 買収・投下資本引き上げ
    • 合意・提携・協力
    • 地域的拡張
    • その他

第11章 企業プロファイル

  • イントロダクション
    • 地域別の収益構成
    • 戦略的ベンチマーキング
  • F. HOFFMAN-LA ROCHE LTD.
  • HAEMONETICS CORPORATION
  • SYSMEX CORPORATION
  • SIEMENS AG
  • ACCRIVA DIAGNOSTICS
  • HELENA LABORATORIES CORPORATION
  • BIO/DATA CORPORATION
  • SENTINEL CH. S.P.A.
  • TEM GROUP
  • AGGREDYNE, INC.
    • 概要
    • 財務情報
    • 製品・サービス
    • 戦略
    • 近年の発展動向、など

第12章 付録

図表

目次
Product Code: BT 3643

The global platelet aggregation devices market is poised to grow at a CAGR of 21.0% during the forecast period (2015-2020), and is expected to reach a value of ~$342.4 million by 2020. Mature markets (such as the U.S., Germany, France, and the U.K.) hold large shares in the global platelet aggregation devices market, and the North American region (particularly the U.S.) is expected to grow at the highest CAGR in the forecast period. Overall growth in the global platelet aggregation devices market is driven by the rising incidences of target diseases, rapid growth in the geriatric population across the globe, technological advancements in platelet aggregometers, and increasing number of industry-academia collaborations and clinical studies. However, factors such as procedural limitations, unfavorable healthcare reforms in the U.S., and dearth of well trained and skilled professionals are restraining the growth of this market. In addition, stringent regulatory policies and limited medical reimbursements are posing significant challenges for the growth of the platelet aggregation devices market.

In this report, the global platelet aggregation devices market is segmented on the basis of products (systems, reagents, and consumables and accessories), applications (research applications and clinical applications), and end users (standalone hospitals, diagnostic laboratories, research and academic institutes, and other end users). The systems segment is expected to account for the largest share of the global platelet aggregation products market in 2015, followed by the reagents segment. Factors such as continuous technological advancements in the field of sensors and detectors, rising trend of automation of platelet aggregation testing procedures, growing adoption and market preference for automated instruments among diagnostic laboratories, and improved patient compliance offered by point-of-care testing analyzers as compared to conventional instruments are driving the growth of the platelet aggregation systems market.

Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the global platelet aggregation devices market in 2015, followed by Europe. North America is also poised to grow at the highest CAGR during the forecast period, owing to factors such as large patient population for target diseases, strong presence of device manufacturers, growing number of surgical procedures, rising awareness among healthcare professionals (related to the benefits offered by platelet aggregation testing in disease diagnosis), large number of patients undergoing cardiovascular surgeries, and increasing prevalence of orthopedic, urological, and bleeding disorders. The global platelet aggregation devices market is moderately competitive with the presence of various global as well as local players. As of 2014, the global platelet aggregation devices market was dominated by F. Hoffmann La-Roche Ltd. (Switzerland), Haemonetics Corporation (U.S.), Sysmex Corporation (Japan), Siemens AG (Germany), and Accriva Diagnostics (U.S.), that together accounted for ~85.0% of the market. New product launches; partnerships, agreements, and collaborations; and strategic acquisitions and divestments are the major strategies adopted by most of the market players to achieve growth in the global platelet aggregation devices market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis such as market share analysis of top ten players and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments of the platelet aggregation devices market, and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms garner higher market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on platelet aggregation products offered by the top 10 players in the global platelet aggregation devices market. The report analyzes the platelet aggregation devices market by product, application, and end user across key geographic regions
  • Product Development/Innovation: Detailed insights on upcoming platelet aggregation testing technologies, research and development activities, and new product launches in the global platelet aggregation devices market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various platelet aggregation products across key geographic regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global platelet aggregation devices market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the global platelet aggregation devices market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. GEOGRAPHIC SCOPE
    • 1.3.3. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Breakdown of primaries
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. BOTTOM-UP APPROACH
    • 2.2.2. TOP-DOWN APPROACH
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. RESEARCH ASSUMPTIONS
    • 2.4.1. ASSUMPTIONS

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT MARKET SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL PLATELET AGGREGATION DEVICES MARKET, 2015-2020
  • 4.2. GLOBAL PLATELET AGGREGATION DEVICES MARKET, BY REGION (2015-2020)
  • 4.3. PLATELET AGGREGATION DEVICES MARKET, BY PRODUCT (2015)
  • 4.4. GLOBAL PLATELET AGGREGATION DEVICES MARKET, BY APPLICATION (2015-2020)
  • 4.5. GLOBAL PLATELET AGGREGATION DEVICES MARKET, BY END USER (2015-2020)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. KEY MARKET DRIVERS
      • 5.3.1.1. Rising incidence of target diseases
      • 5.3.1.2. Rapid growth in the geriatric population across the globe
      • 5.3.1.3. Technological advancements in platelet aggregometers
      • 5.3.1.4. Increasing number of industry-academia collaborations and clinical studies
    • 5.3.2. KEY MARKET RESTRAINTS
      • 5.3.2.1. Procedural limitations
      • 5.3.2.2. Unfavorable healthcare reforms in the U.S.
      • 5.3.2.3. Dearth of well-trained, skilled, and experienced professionals
    • 5.3.3. KEY MARKET OPPORTUNITIES
      • 5.3.3.1. Emerging markets
      • 5.3.3.2. Advent of point-of-care & miniaturized platelet aggregometers
    • 5.3.4. KEY MARKET CHALLENGES
      • 5.3.4.1. Stringent regulatory policies
      • 5.3.4.2. Limited medical reimbursements

6. PLATELET AGGREGATION DEVICES MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. SYSTEMS
  • 6.3. REAGENTS
  • 6.4. CONSUMABLES AND ACCESSORIES

7. PLATELET AGGREGATION DEVICES MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. CLINICAL APPLICATIONS
    • 7.2.1. CARDIOVASCULAR APPLICATIONS
    • 7.2.2. ORTHOPEDIC APPLICATIONS
    • 7.2.3. OTHER CLINICAL APPLICATIONS
  • 7.3. RESEARCH APPLICATIONS

8. PLATELET AGGREGATION DEVICES MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. STANDALONE HOSPITALS
  • 8.3. DIAGNOSTIC LABORATORIES
  • 8.4. RESEARCH AND ACADEMIC INSTITUTES
  • 8.5. OTHER END USERS

9. PLATELET AGGREGATION DEVICES MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. U.K.
    • 9.3.3. FRANCE
    • 9.3.4. REST OF EUROPE (ROE)
  • 9.4. ASIA-PACIFIC
    • 9.4.1. JAPAN
    • 9.4.2. CHINA
    • 9.4.3. INDIA
    • 9.4.4. REST OF ASIA-PACIFIC (ROAPAC)
  • 9.5. REST OF THE WORLD (ROW)

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
  • 10.3. COMPETITIVE SCENARIO
  • 10.4. RECENT DEVELOPMENTS
    • 10.4.1. NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS
    • 10.4.2. ACQUISITIONS AND DIVESTMENTS
    • 10.4.3. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 10.4.4. GEOGRAPHICAL EXPANSIONS
    • 10.4.5. OTHER DEVELOPMENTS

11. COMPANY PROFILES (Overview, Financials, Products & Services, Strategy, & Developments)*

  • 11.1. INTRODUCTION
    • 11.1.1. GEOGRAPHIC REVENUE MIX
    • 11.1.2. STRATEGIC BENCHMARKING
      • 11.1.2.1. Product development and commercialization
  • 11.2. F. HOFFMAN-LA ROCHE LTD.
  • 11.3. HAEMONETICS CORPORATION
  • 11.4. SYSMEX CORPORATION
  • 11.5. SIEMENS AG
  • 11.6. ACCRIVA DIAGNOSTICS
  • 11.7. HELENA LABORATORIES CORPORATION
  • 11.8. BIO/DATA CORPORATION
  • 11.9. SENTINEL CH. S.P.A.
  • 11.10. TEM GROUP
  • 11.11. AGGREDYNE, INC.

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.4. AVAILABLE CUSTOMIZATIONS
  • 12.5. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: RISE IN TARGET PATIENT POPULATION IS REPLICATING INTO HIGHER MARKET DEMAND FOR PLATELET AGGREGATION PRODUCTS
  • TABLE 2: PROCEDURAL LIMITATIONS RELATED TO PLATELET AGGREGOMETRY IS RESULTING IN ITS SUBDUED ADOPTION AMONG HEALTHCARE PROFESSIONALS
  • TABLE 3: EMERGING MARKETS OFFERS SIGNIFICANT GROWTH OPPORTUNITIES IN PLATELET AGGREGATION DEVICES MARKET
  • TABLE 4: STRINGENT REGULATORY FRAMEWORK IS NEGATIVELY AFFECTING THE MARKET GROWTH IN THE U.S.
  • TABLE 5: GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 6: PLATELET AGGREGATION SYSTEMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 7: PLATELET AGGREGATION REAGENTS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 8: PLATELET AGGREGATION CONSUMABLES AND ACCESSORIES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 9: GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 10: GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE FOR CLINICAL APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 11: PLATELET AGGREGATION DEVICES MARKET SIZE FOR CLINICAL APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 12: PLATELET AGGREGATION DEVICES MARKET SIZE FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 13: PLATELET AGGREGATION DEVICES MARKET SIZE FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 14: PLATELET AGGREGATION DEVICES MARKET SIZE FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 15: PLATELET AGGREGATION DEVICES MARKET SIZE FOR RESEARCH APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 16: GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 17: PLATELET AGGREGATION DEVICES MARKET SIZE FOR STANDALONE HOSPITALS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 18: PLATELET AGGREGATION DEVICES MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 19: PLATELET AGGREGATION DEVICES MARKET SIZE FOR RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 20: PLATELET AGGREGATION DEVICES MARKET SIZE FOR OTHER END USERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 21: PLATELET AGGREGATION DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 22: NORTH AMERICA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 23: NORTH AMERICA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 24: NORTH AMERICA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 25: NORTH AMERICA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 26: U.S.: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 27: U.S.: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 28: U.S.: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 29: CANADA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 30: CANADA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 31: CANADA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 32: EUROPE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 33: EUROPE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 34: EUROPE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 35: EUROPE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 36: GERMANY: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 37: GERMANY: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 38: GERMANY: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 39: U.K.: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 40: U.K.: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 41: U.K.: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 42: FRANCE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 43: FRANCE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 44: FRANCE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 45: ROE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 46: ROE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 47: ROE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 48: ASIA-PACIFIC: PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 49: ASIA-PACIFIC: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 50: ASIA-PACIFIC: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 51: ASIA-PACIFIC: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 52: JAPAN: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 53: JAPAN: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 54: JAPAN: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 55: CHINA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 56: CHINA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 57: CHINA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 58: INDIA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 59: INDIA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 60: INDIA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 61: ROAPAC: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 62: ROAPAC: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 63: ROAPAC: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 64: ROW: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 65: ROW: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 66: ROW: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 67: NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS, 2012-2015
  • TABLE 68: ACQUISITIONS AND DIVESTMENTS, 2012-2015
  • TABLE 69: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2012-2015
  • TABLE 70: GEOGRAPHICAL EXPANSIONS, 2012-2015
  • TABLE 71: OTHER DEVELOPMENTS, 2012-2015

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BOTTOM-UP APPROACH
  • FIGURE 3: TOP-DOWN APPROACH
  • FIGURE 4: DATA TRIANGULATION
  • FIGURE 5: ASSUMPTIONS OF THE RESEARCH STUDY
  • FIGURE 6: PLATELET AGGREGATION DEVICES MARKET SHARE: KEY MARKET PLAYERS, 2014
  • FIGURE 7: FUTURE TRENDS: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE (2015-2020)
  • FIGURE 8: FUTURE TRENDS: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION (2015-2020)
  • FIGURE 9: FUTURE TRENDS: PLATELET AGGREGATION DEVICES MARKET SHARE, BY REGION (2015-2020)
  • FIGURE 10: ATTRACTIVE MARKET OPPORTUNITIES IN THE PLATELET AGGREGATION DEVICES MARKET
  • FIGURE 11: CHINA, U.S., & INDIA TO LEAD THE PLATELET AGGREGATION DEVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 12: NORTH AMERICA IS EXPECTED TO COMMAND THE LARGEST SHARE OF THE PLATELET AGGREGATION PRODUCTS MARKET IN 2015
  • FIGURE 13: CHINA TO LEAD THE MARKET FOR PLATLET AGGREGATION DEVICE APPLICATIONS DURING THE FORECAST PERIOD
  • FIGURE 14: STANDALONE HOSPITALS TO BE THE KEY END-USER SEGMENT ACROSS ALL THE KEY REGIONS FOR PLATELET AGGREGATION PRODUCTS
  • FIGURE 15: KEY FACTORS IMPACTING GROWTH OF THE PLATELET AGGREGATION DEVICES MARKET DURING 2015-2020
  • FIGURE 16: INCREASING PROPORTION OF GERIATRIC INDIVIDUALS IN THE TOTAL POPULATION (2012 VS. 2020)
  • FIGURE 17: GLOBAL TREND IN THE GOVERNMENT HEALTHCARE EXPENDITURE: DEVELOPED VS DEVELOPING NATIONS (2010-2012)
  • FIGURE 18: PLATELET AGGREGATION SYSTEMS TO GROW THE FASTEST AMONG ALL PRODUCTS CATEGORIES DURING 2015 TO 2020
  • FIGURE 19: PLATELET AGGREGATION DEVICES MARKET IS EXPECTED TO WITNESS HIGHER GROWTH FOR CLINICAL APPLICATIONS SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 20: GROWING GERIATRIC POPULATION IS EXPECTED TO FUEL THE MARKET DEMAND DURING THE FORECAST PERIOD
  • FIGURE 21: PLATELET AGGREGATION RESEARCH APPLICATIONS MARKET IN NORTH AMERICA IS POISED TO GROW AT THE HIGHEST CAGR DURING 2015-2020
  • FIGURE 22: STANDALONE HOSPITALS TO WITNESS HIGHEST GROWTH AMONG ALL END USERS (2015-2020)
  • FIGURE 23: RISING HEALTHCARE EXPENDITURE ACROSS THE GLOBE TO STIMULATE THE MARKET DEMAND OF PLATELET AGGREGATION TESTING PRODUCTS (2010-2012)
  • FIGURE 24: LARGE NUMBER OF ONGOING CLINICAL TRIALS IS PROPELLING THE DEMAND FOR PLATELET AGGREGATION TESTING PRODUCTS BY PHARMA & BIOTECH COMPANIES (2015)
  • FIGURE 25: NORTH AMERICA TO LEAD THE PLATELET AGGREGATION DEVICES MARKET AMONG KEY REGIONS DURING 2015-2020
  • FIGURE 26: THE NORTH AMERICAN PLATELET AGGREGATION DEVICES MARKET IS MAINLY DRIVEN BY HIGH INCIDENCES OF TARGET DISEASES IN THIS REGION
  • FIGURE 27: PLATELET AGGREGATION SYSTEMS TO CONTRIBUTE THE MAXIMUM TO THE PLATELET AGGREGATION PRODUCTS MARKET GROWTH IN THE U.S. DURING THE FORECAST PERIOD
  • FIGURE 28: EUROPEAN MARKET SNAPSHOT: GERMANY IS EXPECTED TO COMMAND THE LARGEST MARKET SHARE IN 2015
  • FIGURE 29: CLINICAL APPLICATIONS TO HOLD THE LARGER MARKET SHARE IN THE PLATELET AGGREGATION DEVICES APPLICATIONS MARKET IN THE U.K. (2015-2020)
  • FIGURE 30: ASIA-PACIFIC MARKET SNAPSHOT: CHINA IS EXPECTED TO BE THE FASTEST-GROWING REGIONAL SEGMENT IN APAC (2015-2020)
  • FIGURE 31: STANDALONE HOSPITALS SEGMENT IS PROJECTED TO BE THE FASTEST-GROWING END-USER SEGMENT IN CHINA (2015-2020)
  • FIGURE 32: LEADING MARKET PLAYERS ADOPTED PIPELINE DEVELOPMENT & PRODUCT ENHANCEMENT AS THEIR KEY GROWTH STRATEGY DURING 2012 TO 2015
  • FIGURE 33: GLOBAL PLATELET AGGREGATION DEVICES MARKET SHARE, BY KEY PLAYER, 2014**
  • FIGURE 34: CONTINUOUS PRODUCT DEVELOPMENT & COMMERCIALIZATION IS STIMULATING MARKET COMPETITION AMONG KEY PLAYERS
  • FIGURE 35: GEOGRAPHIC REVENUE MIX OF THE TOP FOUR PLAYERS (2014)*
  • FIGURE 36: STRATEGIC BENCHMARKING: LEADING COMPANIES FOCUS ON PRODUCT COMMERCIALIZATION TO STRENGTHEN THEIR MARKET POSITION
  • FIGURE 37: F. HOFFMAN-LA ROCHE LTD.: COMPANY SNAPSHOT
  • FIGURE 38: HAEMONETICS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 39: SYSMEX CORPORATION: COMPANY SNAPSHOT
  • FIGURE 40: SIEMENS AG : COMPANY SNAPSHOT
Back to Top